Saskia Biskup

Managing Director CeGaT GmbH

Seminars

Thursday 19th February 2026
Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System
5:00 pm
  • Designing vaccines to prime and activate the patient’s own immune system to recognize and attack specific GBM cells
  • Identifying and utilizing GBM specific tumor antigens to develop targeted and effective vaccine strategies
  • Focussing on GBM vaccines in combination with other modalities to overcome the TME and boost anti-tumor response
Saskia Biskup, speaking at the 7th Glioblastoma Drug Development Summit